Cleared Special

NIHON KOHDEN BEDSIDE MONITOR, BSM 9100A SERIES (K082785) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2008
Decision
64d
Days
Class 2
Risk

K082785 is an FDA 510(k) clearance for the NIHON KOHDEN BEDSIDE MONITOR, BSM 9100A SERIES. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Nihon Kohden America, Inc. (Foothill, US). The FDA issued a Cleared decision on November 26, 2008 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Nihon Kohden America, Inc. devices

Submission Details

510(k) Number K082785 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2008
Decision Date November 26, 2008
Days to Decision 64 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 125d · This submission: 64d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 160
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K082785.
MODIFICATION TO DASH 2500 PATIENT MONITOR
K090702 · Ge Medical Systems Information Technologies · Apr 2009
CAPNOSTAT / CAPNOFLEX CO2 SYSTEM
K083750 · Ge Medical Systems Information Technologies · Mar 2009
BSM-2300 &BSM6000 WITH CGS-9001 SERIES COMMUNICATION GATEWAY, MODEL CGS-9001 SERIES OPTIONAL ACCESSORY
K083271 · Nihon Kohden America, Inc. · Dec 2008
BENEVIEW T SERIES PATIENT MONITORS, MODELS T8, T6 AND T5
K073280 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 2008
APEXPRO TELEMETRY SYSTEMS
K080251 · Ge Medical Systems Information Technologies · Jun 2008
PREFENSE EDNS-9000 SERIES NURSE CENTRAL STATION
K073550 · Nihon Kohden America, Inc. · Mar 2008